• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hill-Rom To Acquire Voalte, Inc.

Share:

March 18, 2019

Hill-Rom Holdings, Inc., today announced that it has entered into a definitive agreement to acquire Voalte, Inc., a pioneer and leader in real-time, mobile healthcare communications, for a cash consideration of $180 million and up to an additional $15 million in payments related to the achievement of certain commercial milestones. The acquisition of Voalte accelerates Hill-Rom’s leadership in care communications and advances the company’s digital and mobile communications platform and capabilities.

Voalte was founded in 2008 on the vision of simplifying communications and improving workflows and outcomes across the healthcare system. The company, based in Sarasota, Florida, currently serves more than 200 healthcare customers with more than 84,000 devices on its unique mobile platform. With annual revenue approaching $40 million, Voalte has demonstrated a consistent track record of driving durable, double-digit revenue growth and features a steady recurring revenue stream. Voalte’s comprehensive communications platform, which currently connects 220,000 caregivers across the healthcare enterprise, supporting voice, alarm and text communications, will be integrated with Hill-Rom’s care communications business. This combination will further strengthen Hill-Rom’s connected solutions, including smart hospital beds, vital signs monitors, the LINQ™ mobile application and its evolving digital offering, to deliver better care to patients and their care teams.

“Interoperability and connectivity have become critical elements in providing quality healthcare, reducing length of stay and driving efficiencies across the healthcare continuum,” said John P. Groetelaars, president and CEO of Hill-Rom. “This transaction strategically fits with our vision of advancing connected care to improve workflow and real-time actionable insights at the point of care, while driving accelerated growth and delivering an attractive margin profile. We look forward to welcoming and working closely with the talented Voalte team, and benefiting from Voalte’s technology, capabilities and substantial installed customer base to enhance outcomes for patients and their caregivers.”

“Our scalable enterprise communication platform is proving to be a critical tool in the digital transformation of healthcare systems, and we look forward to further developing our platform in alignment with Hill-Rom’s vision of advancing connected care,” said Trey Lauderdale, CEO of Voalte. “Bringing our companies together will allow us to offer customers a single, integrated solution – delivering actionable data from smart hospital beds, nurse call and patient monitoring technology right to a caregiver’s mobile device.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Hill-Rom expects this transaction to close during its fiscal third quarter of 2019, subject to customary closing conditions. The transaction is expected to be modestly dilutive to adjusted earnings per diluted share in fiscal 2019, and increasingly accretive in fiscal 2020 and beyond. The company expects to absorb the dilutive impact in 2019, and does not expect the transaction to have a material impact on its fiscal 2019 adjusted earnings guidance. The company will provide additional information on its fiscal second quarter earnings conference call.

Date: March 18, 2019

Source: Hill-Rom

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Nuclear Medicine or Radiopharmaceuticals Market Modest Analysis with Global Business Trends, Share, Progress Insight, Statistics, Regional and Forecast to 2026Nuclear Medicine or Radiopharmaceuticals Market Modest Analysis with Global Business Trends, Share, Progress Insight, Statistics, Regional and Forecast to 2026
  • New Health Innovation Programme Launches To Improve Patient CareNew Health Innovation Programme Launches To Improve Patient Care
  • Aesthetic Medical International Holdings Group Limited to Acquire Controlling Interest in Jiangsu Liangyan Hospital Management Co., Ltd., Marking the 3rd Acquisitions in 2020Aesthetic Medical International Holdings Group Limited to Acquire Controlling Interest in Jiangsu Liangyan Hospital Management Co., Ltd., Marking the 3rd Acquisitions in 2020
  • Foresight Biosciences & Van Heron Labs Form a Strategic AlignmentForesight Biosciences & Van Heron Labs Form a Strategic Alignment
  • Xencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate CancerXencor Enters Collaboration with Janssen with Aim to Discover Novel CD28 Bispecific Antibodies for the Treatment of Prostate Cancer
  • Data Genomix Acquired by Hickok IncorporatedData Genomix Acquired by Hickok Incorporated
  • Cascade Vision Center Merges with Sterling VisionCascade Vision Center Merges with Sterling Vision
  • Why Apple and Johnson & Johnson’s New Heart Study is a Big Deal for Digital HealthWhy Apple and Johnson & Johnson’s New Heart Study is a Big Deal for Digital Health

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications